Last reviewed · How we verify
enhanced DefenAge 8-in-1 BioSerum
enhanced DefenAge 8-in-1 BioSerum is a topical anti-aging agent Small molecule drug developed by Goldman, Butterwick, Fitzpatrick and Groff. It is currently in Phase 3 development for Treatment of fine lines and wrinkles, skin discoloration, and other signs of aging.
Enhanced DefenAge 8-in-1 BioSerum is a topical serum that targets multiple signs of aging through a combination of peptides, growth factors, and other bioactive molecules.
Enhanced DefenAge 8-in-1 BioSerum is a topical serum that targets multiple signs of aging through a combination of peptides, growth factors, and other bioactive molecules. Used for Treatment of fine lines and wrinkles, skin discoloration, and other signs of aging.
At a glance
| Generic name | enhanced DefenAge 8-in-1 BioSerum |
|---|---|
| Sponsor | Goldman, Butterwick, Fitzpatrick and Groff |
| Drug class | topical anti-aging agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
It works by stimulating collagen production, improving skin elasticity, and reducing the appearance of fine lines and wrinkles. The serum also contains antioxidants and other anti-aging compounds that help to protect the skin from environmental stressors and promote a more youthful appearance.
Approved indications
- Treatment of fine lines and wrinkles, skin discoloration, and other signs of aging
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- enhanced DefenAge 8-in-1 BioSerum CI brief — competitive landscape report
- enhanced DefenAge 8-in-1 BioSerum updates RSS · CI watch RSS
- Goldman, Butterwick, Fitzpatrick and Groff portfolio CI
Frequently asked questions about enhanced DefenAge 8-in-1 BioSerum
What is enhanced DefenAge 8-in-1 BioSerum?
How does enhanced DefenAge 8-in-1 BioSerum work?
What is enhanced DefenAge 8-in-1 BioSerum used for?
Who makes enhanced DefenAge 8-in-1 BioSerum?
What drug class is enhanced DefenAge 8-in-1 BioSerum in?
What development phase is enhanced DefenAge 8-in-1 BioSerum in?
What are the side effects of enhanced DefenAge 8-in-1 BioSerum?
Related
- Drug class: All topical anti-aging agent drugs
- Manufacturer: Goldman, Butterwick, Fitzpatrick and Groff — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Treatment of fine lines and wrinkles, skin discoloration, and other signs of aging
- Compare: enhanced DefenAge 8-in-1 BioSerum vs similar drugs
- Pricing: enhanced DefenAge 8-in-1 BioSerum cost, discount & access